National guideline for the management of anogenital warts

Sexually Transmitted Infections

Volumn 75, Issue SUPPL. 1, 1999, Pages

  Maw, Raymond ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; INTERFERON; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID;

ANUS DISEASE; CONDYLOMA; CRYOSURGERY; ELECTROSURGERY; HUMAN; LASER SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; VERRUCA VULGARIS; VIRUS CHARACTERIZATION; WART VIRUS;

EID: 0342464432     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Koutsky T., Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
2. Voog E, Lowhagen G-B. Follow up of men with genital papilloma virus infection: psychosexual aspects. Acta Derm Venereol (Stockh) 1992;72:185-6.
3. Rymark P, Forslund O, Hansson B-G, et al. Genital human papillomavirus infection is not a local but regional infection. Genitourin Med 1993;69:18-22.
4. Oriel JD. Natural history of genital warts. Br J Vener Dis 1971;47:1-13.
5. Thomas I, Wright G, Ward B.The effect of condom use on cervical intraepithelial neoplasia grade I (CIN 1). Aust NZ J Obstet Gynaecol 1990;30:236-9.
6. Pakianathan MR, Ross JDC, McMillan A. Characterizing patients with multiple sexually acquired infections: a multivariate analysis. Int J STD AIDS 1996;7:359-61.
7. Wikstrom A, von Krogh G, Hedblad M-A, et al. Papillomavirus-associated balanoposthitis. Genitourin Med 1994;70:175-81.
8. Boden E, Eriksson A, Rylander E, et al. Clinical characteristics of papillomavirus-vulvovaginitis. Acata Obstet Gynecol Scand 1988;67:147-51.
9. Wikstrom A, Hedblad M-A, Johansson B, et al. The acetic acid test in evaluation of subclinical genital papillomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med 1992;68:90-9.
10. Voog E, Genital viral infections. Studies on human papillomavirus and Epstein-Harr virus. Acta Dermato-Vener (Suppl) 1996;198:1-55.
11. Riva JM, Sedlack TV, Cunnane MF, et al. Extended carbon dioxide laser vaporisation in the treatment of subclinical papillomavirus infection of the lower genital tract. Obstet Gynecol 1989;73:25-30.
12. Krebs H-B, Helmkamp BF. Treatment failure of genital condylomata acuminata in women: role of the male sexual partner. Am J Obstet Gynecol 1991;165:337-9.
13. Eron LJ. Human papillomaviruses and anogenital disease. In: Gorbach SL, Bartlett JG, Blacklow NK, eds. Infections diseases. Philadelphia: WE Saunders, 1992: 952-6.
14. Beutner KR, Wiley DJ. Recurrent external genital warts: a literature review. Papillomavirus Res 1997;8:69-74.
15. Maiti H, Hay KR. Self-treatment of condylomata acuminata with podophyllin resin. Practitioner 1985;229:37-9.
16. Centres for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. Human papillomavirus infection. MMWR 1993;42(No RR-14).
17. Petersen CS, Weismann K. Quercetin and kaempherol: an argument against the use of podophyllin? Genitourin Med 1995;71:92-3.
18. Von Krogh G. 5-Fluorouracil cream in the successful treatment of therapeutically refractory condylomata acuminata of the urinary meatus. Acta Dermatol Venereol (Stockh) 1976;56:297-300.
19. 2 laser for treatment of vaginal condylomata. Obstet Gynecol 1984;64: 773-8.
20. Reid R, Greenberg MD, Lorincz AT, et al. Superficial laser vaporization and adjunctive 5-fluorouracil therapy of human papillomavirus-associated vulvar disease. Obstet Gynecol 1990;76:439-48.
21. Krebs HB, Helmkamp BF. Chronic ulcerations following topical therapy with 5-fluorouracil for vaginal human papillomavirus-associated lesions. Obstet Gynecol 1991;78: 205-8.
22. Goodman A, Zukerberg LR, Nikrui N, et al. Vaginal adenosis and clear cell carcinoma after 5-fluorouracil treatment for condylomas. Cancer 1991;68:1628-32.
23. 2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial (letter). Genitourin Med 1996;72:71.
24. Tomai MA, Miller RL, Slade HB, et al. A novel topical immune response modifier induces cytokine production in human keratinocytes and skin, 6th Congress of the European Academy of Dermatology and Venereology, Dublin, 1997 (abstract).
25. Trofatter K, Beutner K, Edwards L, et al. Two vehicle-controlled trials of topical imiquimod for the treatment of genital/perianal condylomara acuminata. 6th Congress of the European Academy of Dermatology and Venercology, Dublin, 1997 (abstract).
26. Bonnez W, Oakes D, Choi A, et al. Therapeutic efficacy and complications of excisional biopsy of condyloma acuminatum. Sex Transm Dis 1996;23:273-6.
27. Gross GE, Barrasso R. General principles of treatment. In: Gross GF, Barrasso R, eds. Human papillomavirus infection. A clinical atlas. Berlin: Ullstein Mosby, 1997:54-6.
28. Ferenczy A. Laser therapy of genital condylomata acuminata. Obstet Gynecol 1984;63:703-7.
29. 2 laser-generated plume of smoke and its consequences to the surgeon. Obstet Gynecol 1990;75:114-18.
30. Murphy M, Fairley I, Wilson J. Exophytic cervical warts - an indication for colposcopy? Genitourin Med 1993; 69:81-2.
31. Mounts P, Shah KV, Kashima H. Viral aetiology of juvenile and adult onset squamous papilloma of the larynx. Proc Natl Acad Sci USA 1982;79:5425-9.
32. Menton M, Neeser E, Walker S, et al. Condylomata acuminata in pregnancy. Is there an indication for Cesarean section? (German) Geburtshilfe und Frauenheilkunde 1993;53: 681-3.
33. Duncan I, ed. Guidelines for clinical practice and programme management. 2nd ed. London: NHS Cervical Screening Programme Publication No 8, December 1997.
34. Reynolds M, Fraser PA, Lacey CJN. Audits of the treatment of genital warts; closing the feedback loop. Int J STD AIDS 1996;7:347-52.